TP53 and central nervous system cancer: Likewise, in lower-grade glioma we provided evidence that TP53 status is an independent predictor of overall survival in various molecular and histological subgroups, including the IDH1R132X subgroup, which was recently reported to have better outcomes than the IDH1R132H subgroup [33].